CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion (Q46151813)

20 December 2017

title

CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion (English)

1 reference

20 December 2017

0 references

0 references

0 references

1

1 reference

20 December 2017

Maria Bertolotto

6

1 reference

20 December 2017

Fabienne Burger

4

object named as

Fabienne Burger

1 reference

PubMed ID

19162037

20 December 2017

Vincent Braunersreuther

3

object named as

Vincent Braunersreuther

1 reference

20 December 2017

Sébastien Lenglet

2

1 reference

20 December 2017

Graziano Pelli

5

1 reference

20 December 2017

François Mach

7

1 reference

20 December 2017

Sabine Steffens

8

1 reference

20 December 2017

publication date

7 January 2009

1 reference

20 December 2017

Journal of Molecular and Cellular Cardiology

published in

1 reference

20 December 2017

volume

46

1 reference

20 December 2017

page(s)

612-620

1 reference

20 December 2017

issue

5

1 reference

20 December 2017

Myocardial reperfusion injury.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Cannabinoid receptors in acute and chronic complications of atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

The endocannabinoid system: a general view and latest additions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

The cannabinoid system and immune modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Identification and functional characterization of brainstem cannabinoid CB2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Endocannabinoids protect the rat isolated heart against ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

The novel adipocytokine visfatin exerts direct cardioprotective effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Tumor necrosis factor-alpha (TNF-α) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1α) on human neutrophils through defined signalling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

The inflammatory response in myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Intracoronary, adenovirus-mediated Akt gene transfer in heart limits infarct size following ischemia-reperfusion injury in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Cardioprotection: nitric oxide, protein kinases, and mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

The myocardial JAK/STAT pathway: from protection to failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Ischemic postconditioning in pigs: no causal role for RISK activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Changes in activation states of murine polymorphonuclear leukocytes (PMN) during inflammation: a comparison of bone marrow and peritoneal exudate PMN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Leukocyte migration and activation by murine chemokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YJMCC.2008.12.014

1 reference

20 December 2017

PubMed ID

19162037

1 reference

20 December 2017